Authors: Maliepaard, M van Gastelen, MA Tohgo, A Hausheer, FH van Waardenburg, RCAM de Jong, LA Pluim, D Beijnen, JH Schellens, JHM

Citation: M. Maliepaard et al., Circumvention of breast cancer resistance protein (BCRP)-mediated resistance to camptothecins in vitro using non-substrate drugs or the BCRP inhibitor GF120918, CLIN CANC R, 7(4), 2001, pp. 935-941

Authors: Maliepaard, M Scheffer, GL Faneyte, IF van Gastelen, MA Pijnenborg, ACLM Schinkel, AH van de Vijver, MJ Scheper, RJ Schellens, JHM

Citation: M. Maliepaard et al., Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues, CANCER RES, 61(8), 2001, pp. 3458-3464

Authors: Scheffer, GL Maliepaard, M Pijnenborg, ACLM van Gastelen, MA de Jong, MC Schroeijers, AB van der Kolk, DM Allen, JD Ross, DD van der Valk, P Dalton, WS Schellens, JHM Scheper, RJ

Citation: Gl. Scheffer et al., Breast cancer resistance protein is localized at the plasma membrane in mitoxantrone- and topotecan-resistant cell lines, CANCER RES, 60(10), 2000, pp. 2589-2593

Authors: Maliepaard, M van Gastelen, MA de Jong, LA Pluim, D van Waardenburg, RCAM Ruevekamp-Helmers, MC Floot, BGJ Schellens, JHM

Citation: M. Maliepaard et al., Overexpression of the BCRP/MXR/ABCP gene in a topotecan-selected ovarian tumor cell line, CANCER RES, 59(18), 1999, pp. 4559-4563